{
  "ZZ4829Q_syn_1": "Indication: RUL NSCLC Staging.\nProc: EBUS-TBNA.\nActions:\n- 4R: 5 passes (Benign).\n- 7: 3 passes (Malignant).\n- 11R: 3 passes (Benign).\nResult: N2 disease (Station 7).\nPlan: Molecular testing.",
  "ZZ4829Q_syn_2": "PROCEDURE NOTE: Mediastinal staging was performed for RUL NSCLC. Station 4R required 5 passes to achieve adequacy and was found to be benign. Station 7 was PET-positive and confirmed malignant on ROSE. Station 11R was benign. N2 disease is confirmed based on Station 7 involvement.",
  "ZZ4829Q_syn_3": "Code: 31653 (EBUS 3+ stations).\nStations: 4R, 7, 11R.\nDetails: 4R required multiple passes for ROSE adequacy. 7 was malignant. 11R benign.\nOutcome: N2 Staging.",
  "ZZ4829Q_syn_4": "Procedure: EBUS Staging\nPatient: [REDACTED]\nSteps:\n1. Mod sedation.\n2. 4R: Hard to get cells, took 5 passes. Benign.\n3. 7: Malignant right away.\n4. 11R: Benign.\n5. Molecular sent from #7.\nPlan: N2 disease management.",
  "ZZ4829Q_syn_5": "george martinez staging for rul cancer. 4r gave us trouble had to pass the needle 5 times to get good cells but it was benign. 7 was positive for cancer. 11r was negative. so he has n2 disease. sent tissue for testing.",
  "ZZ4829Q_syn_6": "Name: [REDACTED]. INDICATION: Mediastinal staging, RUL NSCLC. EBUS-TBNA performed: Station 4R (5 passes needed, ROSE benign). Station 7 (ROSE positive malignancy). Station 11R (ROSE adequate benign). Impression: N2 disease confirmed (station 7).",
  "ZZ4829Q_syn_7": "[Indication]\nRUL NSCLC Staging.\n[Anesthesia]\nModerate.\n[Description]\nEBUS-TBNA. Station 4R (Benign, 5 passes). Station 7 (Malignant). Station 11R (Benign). N2 disease confirmed.\n[Plan]\nMolecular testing.",
  "ZZ4829Q_syn_8": "We staged [REDACTED] today. We had a bit of trouble with station 4R; it took 5 passes to get a good sample, but it turned out to be benign. Station 7, however, was clearly malignant. Station 11R was benign. This confirms he has N2 disease. We sent the tissue from station 7 for genetic profiling.",
  "ZZ4829Q_syn_9": "Procedure: Systematic EBUS-TBNA.\nIndication: Staging of pulmonary carcinoma.\nSampling: Station 4R (benign lymphocytes), Station 7 (malignant cells), Station 11R (benign).\nNote: Extended sampling required for 4R adequacy.\nResult: N2 nodal involvement verified.",
  "ZZ4829Q": "Name: [REDACTED] / MRN: [REDACTED] / Birth: [REDACTED]\n\nINDICATION: Mediastinal staging, RUL NSCLC\n\nSedation: Moderate (midazolam/fentanyl), Ramsay 3, monitoring q5min\n\nEBUS-TBNA performed with systematic approach (N3→N2→N1):\n\nStation 4R (11mm, PET+):\n- Pass 1: ROSE - insufficient cellularity\n- Pass 2: ROSE - insufficient cellularity\n- Pass 3: ROSE - insufficient cellularity\n- Pass 4: ROSE - finally adequate, benign lymphocytes seen\n- Pass 5: ROSE - adequate\n→ 5 total passes needed for adequacy\n\nStation 7 (15mm, PET+):\n- Passes 1-3: ROSE adequate immediately, positive for malignancy\n\nStation 11R (7mm, PET-):\n- Passes 1-3: ROSE adequate\n\nALL NODES ADEQUATE: Yes (eventually, though station 4R required extra passes)\nMOLECULAR SUCCESS: Yes, tissue sent from station 7\n\nSystematic sequence used: Yes\nPhotodocumentation completed: Yes\n\nNo complications.\n\nImpression: N2 disease confirmed (station 7). Station 4R benign despite PET avidity. Adequate tissue for molecular testing obtained."
}
